Gerald Rosen, MD

  • Specialty: Medical Oncology
  • Language: English
  • Phone: 212-731-5758

About Me

I began treating adults and adolescents with malignant bone and soft tissue sarcomas in the 1970s. I dedicated much of my time to improving treatment, becoming a big proponent of outpatient cancer care. Back in the day, this system of care was not so prevalent. Now, it is the model for most major cancer centers.

I came to NYU Langone to create and lead the program in adult sarcoma treatment. To care for people with early stages of sarcoma, I use a combination of radiation therapy and preoperative chemotherapy. I developed the latter to increase cure rates by shrinking tumor size, making the tumors easier to remove during surgery. The process also helps to improve function and quality of life after surgery.

I also see people who have already had treatment and are seeking help for advanced stages of bone and soft tissue sarcomas. I create individualized treatment programs that can help control the condition or restore people’s health—and their hope.

Hope is something we never take away from patients. We aim to always offer a treatment plan that may lead to a long remission. This philosophy has helped to ensure that many cancerous conditions become manageable illnesses. Through it all, we balance treatment with regular adjustments to minimize discomfort and make the process as livable as possible for patients.

We never give up. Looking at all our options, including any new medications and treatments available through clinical trials, we do whatever we can to provide comfort and care.

Conditions and Treatments

bone tumor, bone cancer, bone sarcoma, Ewing's sarcoma, cancer of the soft tissue, adult soft tissue sarcoma, stromal tumor, leiomyosarcoma, synovial sarcoma, pecoma, neurofibrosarcoma, rhabdomyosarcoma, giant cell tumor, angiosarcoma, malignant schwannoma, primitive neuroectodermal tumor (PNET), gastrointestinal stromal tumor (GIST), fibrosarcoma, hemangioendothelioma, retroperitoneal sarcoma, solitary fibrous tumor, spindle cell sarcoma, liposarcoma
Show More Conditions


  • Professor, Department of Medicine
  • Director, Medical Oncology Sarcoma Program
Board Certifications
  • American Board of Pediatrics - Pediatrics, 1975
Education and Training
  • Fellowship, Memorial Sloan-Kettering Cancer Center, Pediatric Hem/onc, 1974
  • Fellowship, National Institute of Health, Biochemistry, 1970
  • MD from Stanford University, 1966

Locations and Appointments

View Insurance Plans Accepted
  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Affinity
    • Affinity
    • Affinity Exchange- Essential
  • Agewell
    • Agewell
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • ElderPlan
    • ElderPlan
  • Emblem
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Family Health
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
    • GHI CBP
  • HIP
    • HIP Access I
    • HIP Access II
    • HIP Child Health
    • HIP Essential
    • HIP Family Health
    • HIP HMO
    • HIP Medicaid
    • HIP Medicare
    • HIP POS
  • HealthSmart
    • HealthSmart (WTC)
  • Healthfirst
    • Healthfirst
    • Healthfirst Essential
  • Hotel Trades
    • Hotel Trades
  • Humana
    • Humana Medicare
    • Independent Care System New York
  • Local 1199
    • Local 1199 PPO
  • MagnaCare
    • MagnaCare PPO
  • Medicaid
    • NY Medicaid
  • Medicare
    • Medicare
  • MetroPlus
    • MetroPlus Child Health
    • MetroPlus Essential
    • MetroPlus Exchange Plans
    • MetroPlus Family Health
    • MetroPlus Medicaid
    • MetroPlus Medicare
  • MultiPlan/PHCS
    • MultiPlan/PHCS PPO
  • NYS
    • NYS Empire Plan
  • Oscar
    • Oscar
  • Oxford
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
  • PHP
    • PHP
  • Tricare
    • Tricare
  • UHC
    • UnitedHealthcare Community & State Plan
    • UnitedHealthcare Core and Charter
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
  • VNS
    • Visiting Nurse Service (VNS) Medicare
  • Village Caremax
    • Village Caremax
  • WellCare
    • WellCare Child Health
    • WellCare Family Health
    • WellCare Medicaid
    • WellCare Medicare
NYU Medical Oncology Associates

160 East 34th Street
New York, NY 10016


Phone: 212-731-5758

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.


  • Adult Primary Spinal Epidural Extraosseous Ewing's Sarcoma: A Case Report and Review of the Literature

    Bustoros, Mark; Thomas, Cheddhi; Frenster, Joshua; Modrek, Aram S; Bayin, N Sumru; Snuderl, Matija; Rosen, Gerald; Schiff, Peter B; Placantonakis, Dimitris G Bustoros, Mark; Thomas, Cheddhi; Frenster, Joshua; Modrek, Aram S; Bayin, N Sumru; Snuderl, Matija; Rosen, Gerald; Schiff, Peter B; Placantonakis, Dimitris G
    Case reports in neurological medicine. 2016. 2016: 1217428-1217428

  • Neoadjuvant Chemotherapy and Radiation Therapy for Soft Tissue Sarcoma in Adults: A Single-Institution Retrospective Review [Meeting Abstract]

    Katz, LM; Rosen, G; Rapp, T; Schiff, PB Katz, LM; Rosen, G; Rapp, T; Schiff, PB
    International journal of radiation oncology biology physics. 2015 NOV 1. 93 (3): E636-E636

  • Progress in the Treatment of Ewing Sarcoma: Are the Rumors of the Demise of Cytotoxic Chemotherapy Premature?

    Rosen, G Rosen, G
    Klinische padiatrie. 2015 May 18. 227 (3): 105-107

Read All Publications (261)